AU2003227373A1 - Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin - Google Patents
Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycinInfo
- Publication number
- AU2003227373A1 AU2003227373A1 AU2003227373A AU2003227373A AU2003227373A1 AU 2003227373 A1 AU2003227373 A1 AU 2003227373A1 AU 2003227373 A AU2003227373 A AU 2003227373A AU 2003227373 A AU2003227373 A AU 2003227373A AU 2003227373 A1 AU2003227373 A1 AU 2003227373A1
- Authority
- AU
- Australia
- Prior art keywords
- clarithromycin
- formulation
- manufacturing
- dosage form
- oral dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000019658 bitter taste Nutrition 0.000 title 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 title 1
- 229960002626 clarithromycin Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000006186 oral dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2003-0019890A KR100508992B1 (en) | 2003-03-31 | 2003-03-31 | Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin |
| KR10-2003-0019890 | 2003-03-31 | ||
| PCT/KR2003/000814 WO2004087112A1 (en) | 2003-03-31 | 2003-04-22 | Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003227373A1 true AU2003227373A1 (en) | 2004-10-25 |
Family
ID=33128925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003227373A Abandoned AU2003227373A1 (en) | 2003-03-31 | 2003-04-22 | Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR100508992B1 (en) |
| AU (1) | AU2003227373A1 (en) |
| WO (1) | WO2004087112A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005082331A2 (en) * | 2004-02-26 | 2005-09-09 | Ranbaxy Laboratories Limited | Extended release tablets of clarithromycin |
| KR100676075B1 (en) * | 2005-02-17 | 2007-02-01 | 한국유나이티드제약 주식회사 | Claricemicin-containing pellet preparations for oral administration |
| KR101436516B1 (en) * | 2007-07-23 | 2014-09-02 | 주식회사태평양제약 | Suspensions containing coated pellets and methods for their preparation |
| CN101502492B (en) * | 2009-03-13 | 2013-11-27 | 上海微丸医药开发有限公司 | Method for preparing clarithromycin granule without bitter taste |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3265680B2 (en) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | Oral pharmaceutical composition |
| US5466712A (en) * | 1994-11-04 | 1995-11-14 | American Home Products Corporation | Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones |
| EP0826376B1 (en) * | 1995-05-02 | 2007-01-24 | Taisho Pharmaceutical Co. Ltd | Composition for oral administration |
| AUPO637197A0 (en) * | 1997-04-23 | 1997-05-15 | F.H. Faulding & Co. Limited | Taste-masked pharmaceutical compositions |
| DE19840256A1 (en) * | 1998-09-03 | 2000-03-09 | Basf Ag | Widely applicable, continuous method for preparing coated solid dosage forms, comprises extruding mixture of drug and thermoplastic binder then applying coating composition in liquid or vapor form |
-
2003
- 2003-03-31 KR KR10-2003-0019890A patent/KR100508992B1/en not_active Expired - Fee Related
- 2003-04-22 WO PCT/KR2003/000814 patent/WO2004087112A1/en not_active Ceased
- 2003-04-22 AU AU2003227373A patent/AU2003227373A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR100508992B1 (en) | 2005-08-17 |
| WO2004087112A1 (en) | 2004-10-14 |
| KR20040085256A (en) | 2004-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003259417A1 (en) | Taste masked dosage forms and processes for their preparation | |
| EP1365747A4 (en) | Oral peptide pharmaceutical dosage form and method of production | |
| GB0219516D0 (en) | Fast dissolving and taste masked oral dosage form comprising sildenafil | |
| AU2002357012A1 (en) | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof | |
| HUP0303800A3 (en) | Pharmaceuticals and dosage forms of epothilones for oral administration | |
| AU2003298583A1 (en) | Chewing gum formulation and method of making the same | |
| HRP20050867A2 (en) | Pharmaceutical compositions having reduced bitter taste | |
| AU2002352533A1 (en) | Methods and compositions for treatment of gastric diseases | |
| AU2003221699A1 (en) | Pharmaceutical preparation for taste masking | |
| SG116507A1 (en) | Pharmaceutical dosage form and method of making. | |
| AU2003227789A1 (en) | Inhalator and method of manufacturing same | |
| AU2003276572A1 (en) | Pharmaceutical dosage forms of biguanide-sulfonylurea combinations | |
| AU2002329311A1 (en) | Pharmaceutical formulation having a masked taste and method for the production thereof | |
| ZA200309479B (en) | Pharmaceutical formulation having a masked taste and method for the production thereof | |
| AU2003292509A1 (en) | Taste masked pharmaceutical compositions comprising bitter drug and ph sensitive polymer | |
| AU2003237574A1 (en) | Confectionery product and method of preparation | |
| IL163959A (en) | Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them | |
| AU2003249478A1 (en) | Taste masked sumatriptan tablets and processes for their preparation | |
| AU2003227373A1 (en) | Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin | |
| IL175657A0 (en) | Derivatives of dihydronepetalactone and method for preparation | |
| AU2002246950A1 (en) | Hydrocapsules and method of preparation | |
| AU2002242223A1 (en) | Flavored coffee compositions and method of making | |
| IL169428A (en) | Acylaminothiazole derivatives, preparation method thereof, pharmaceutical compositions comprising them and use of same in the manufacture of beta-amyloid peptide production inhibitors | |
| AU2003256157A1 (en) | Oral dosage forms of water insoluble drugs and methods of making the same | |
| ZA200408569B (en) | Taste masked compositions of erythromycin A and derivatives thereof. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |